It is about protecting your results
The body has a finite number of receptor sites
Other studies show that Cotaduide could intervene and reverse NASH through improving metabolism in the liver including lipid and glucose metabolism via GCGR in mice, suggesting that Cotaduide may be a potential and viable therapeutic as a targeted drug intervention to reverse disease progression of NASH (131)
While peptide therapy itself is typically not covered by insurance, we can provide documentation for HSA/FSA and insurance reimbursement
The Phase 2 trial also revealed that nausea, diarrhea, constipation, and vomiting were all more common in retatrutide groups than placebo
Finding your ideal range is unique to each individual, but, more importantly, it requires oversight and approval from your physician